Revolution Medicines, Inc. (RVMD)
190.14
+0.38
(+0.20%)
USD |
NASDAQ |
Oct 12, 12:22
Revolution Medicines Free Cash Flow (Quarterly) : -389.60M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -389.60M |
| March 31, 2026 | -355.70M |
| December 31, 2025 | -276.16M |
| September 30, 2025 | -210.66M |
| June 30, 2025 | -229.21M |
| March 31, 2025 | -197.70M |
| December 31, 2024 | -139.51M |
| September 30, 2024 | -133.94M |
| June 30, 2024 | -130.57M |
| March 31, 2024 | -163.73M |
| December 31, 2023 | -122.88M |
| September 30, 2023 | -103.03M |
| June 30, 2023 | -68.24M |
| March 31, 2023 | -64.15M |
| December 31, 2022 | -64.66M |
| Date | Value |
|---|---|
| September 30, 2022 | -55.26M |
| June 30, 2022 | -58.24M |
| March 31, 2022 | -57.05M |
| December 31, 2021 | -40.45M |
| September 30, 2021 | -37.04M |
| June 30, 2021 | -35.39M |
| March 31, 2021 | -40.82M |
| December 31, 2020 | -26.20M |
| September 30, 2020 | -27.71M |
| June 30, 2020 | -20.46M |
| March 31, 2020 | -28.62M |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | -12.13M |
| March 31, 2019 | -12.95M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Moderna, Inc. | -563.00M |
| Arrowhead Pharmaceuticals, Inc. | -181.32M |
| Intellia Therapeutics, Inc. | -84.92M |
| Twist Bioscience Corp. | -8.648M |
| Beam Therapeutics, Inc. | -68.51M |